157 related articles for article (PubMed ID: 34326002)
1. Editor's Choice - Risk of Major Amputation Following Application of Paclitaxel Coated Balloons in the Lower Limb Arteries: A Systematic Review and Meta-Analysis of Randomised Controlled Trials.
Katsanos K; Spiliopoulos S; Teichgräber U; Kitrou P; Del Giudice C; Björkman P; Bisdas T; de Boer S; Krokidis M; Karnabatidis D
Eur J Vasc Endovasc Surg; 2022 Jan; 63(1):60-71. PubMed ID: 34326002
[TBL] [Abstract][Full Text] [Related]
2. Drug-eluting balloon angioplasty versus uncoated balloon angioplasty for peripheral arterial disease of the lower limbs.
Kayssi A; Al-Atassi T; Oreopoulos G; Roche-Nagle G; Tan KT; Rajan DK
Cochrane Database Syst Rev; 2016 Aug; 2016(8):CD011319. PubMed ID: 27490003
[TBL] [Abstract][Full Text] [Related]
3. Systematic Review and Meta-analysis of Randomized Controlled Trials of Paclitaxel-Coated Balloon Angioplasty in the Femoropopliteal Arteries: Role of Paclitaxel Dose and Bioavailability.
Katsanos K; Spiliopoulos S; Paraskevopoulos I; Diamantopoulos A; Karnabatidis D
J Endovasc Ther; 2016 Apr; 23(2):356-70. PubMed ID: 26823485
[TBL] [Abstract][Full Text] [Related]
4. Risk of Death Following Application of Paclitaxel-Coated Balloons and Stents in the Femoropopliteal Artery of the Leg: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
Katsanos K; Spiliopoulos S; Kitrou P; Krokidis M; Karnabatidis D
J Am Heart Assoc; 2018 Dec; 7(24):e011245. PubMed ID: 30561254
[TBL] [Abstract][Full Text] [Related]
5. Risk of Death and Amputation with Use of Paclitaxel-Coated Balloons in the Infrapopliteal Arteries for Treatment of Critical Limb Ischemia: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
Katsanos K; Spiliopoulos S; Kitrou P; Krokidis M; Paraskevopoulos I; Karnabatidis D
J Vasc Interv Radiol; 2020 Feb; 31(2):202-212. PubMed ID: 31954604
[TBL] [Abstract][Full Text] [Related]
6. Comparative Effectiveness of Plain Balloon Angioplasty, Bare Metal Stents, Drug-Coated Balloons, and Drug-Eluting Stents for the Treatment of Infrapopliteal Artery Disease: Systematic Review and Bayesian Network Meta-analysis of Randomized Controlled Trials.
Katsanos K; Kitrou P; Spiliopoulos S; Diamantopoulos A; Karnabatidis D
J Endovasc Ther; 2016 Dec; 23(6):851-863. PubMed ID: 27708143
[TBL] [Abstract][Full Text] [Related]
7. Longitudinal Assessment of Safety of Femoropopliteal Endovascular Treatment With Paclitaxel-Coated Devices Among Medicare Beneficiaries: The SAFE-PAD Study.
Secemsky EA; Shen C; Schermerhorn M; Yeh RW
JAMA Intern Med; 2021 Aug; 181(8):1071-1080. PubMed ID: 33993204
[TBL] [Abstract][Full Text] [Related]
8. Bayesian network meta-analysis of nitinol stents, covered stents, drug-eluting stents, and drug-coated balloons in the femoropopliteal artery.
Katsanos K; Spiliopoulos S; Karunanithy N; Krokidis M; Sabharwal T; Taylor P
J Vasc Surg; 2014 Apr; 59(4):1123-1133.e8. PubMed ID: 24661896
[TBL] [Abstract][Full Text] [Related]
9. Outcomes After Drug-Coated Balloon Treatment of Femoropopliteal Lesions in Patients With Critical Limb Ischemia: A Post Hoc Analysis From the IN.PACT Global Study.
Reijnen MMPJ; van Wijck I; Zeller T; Micari A; Veroux P; Keirse K; Lee SW; Li P; Voulgaraki D; Holewijn S
J Endovasc Ther; 2019 Jun; 26(3):305-315. PubMed ID: 30931726
[TBL] [Abstract][Full Text] [Related]
10. Editor's Choice - Drug Coated Balloon Angioplasty vs. Standard Percutaneous Transluminal Angioplasty in Below the Knee Peripheral Arterial Disease: A Systematic Review and Meta-Analysis.
Ipema J; Huizing E; Schreve MA; de Vries JPM; Ünlü Ç
Eur J Vasc Endovasc Surg; 2020 Feb; 59(2):265-275. PubMed ID: 31889657
[TBL] [Abstract][Full Text] [Related]
11. Re: "Risk of Major Amputation Following Application of Paclitaxel Coated Balloons in the Lower Limb Arteries: A Systematic Review and Meta-analysis of Randomised Controlled Trials".
Coscas R; Jayet J
Eur J Vasc Endovasc Surg; 2022 Apr; 63(4):661. PubMed ID: 35248440
[No Abstract] [Full Text] [Related]
12. Safety of Paclitaxel-Coated Balloon Angioplasty for Femoropopliteal Peripheral Artery Disease.
Ouriel K; Adelman MA; Rosenfield K; Scheinert D; Brodmann M; Peña C; Geraghty P; Lee A; White R; Clair DG
JACC Cardiovasc Interv; 2019 Dec; 12(24):2515-2524. PubMed ID: 31575518
[TBL] [Abstract][Full Text] [Related]
13. Single-Center Experience With Lutonix Drug-Coated Balloons in Infrapopliteal Arteries.
Steiner S; Schmidt A; Bausback Y; Bräunlich S; Ulrich M; Banning-Eichenseer U; Scheinert D
J Endovasc Ther; 2016 Jun; 23(3):417-23. PubMed ID: 27099285
[TBL] [Abstract][Full Text] [Related]
14. Low-Dose Paclitaxel-Coated Versus Uncoated Percutaneous Transluminal Balloon Angioplasty for Femoropopliteal Peripheral Artery Disease: One-Year Results of the ILLUMENATE European Randomized Clinical Trial (Randomized Trial of a Novel Paclitaxel-Coated Percutaneous Angioplasty Balloon).
Schroeder H; Werner M; Meyer DR; Reimer P; Krüger K; Jaff MR; Brodmann M;
Circulation; 2017 Jun; 135(23):2227-2236. PubMed ID: 28424223
[TBL] [Abstract][Full Text] [Related]
15. Editor's Choice - Long Term Survival after Femoropopliteal Artery Revascularisation with Paclitaxel Coated Devices: A Propensity Score Matched Cohort Analysis.
Behrendt CA; Sedrakyan A; Peters F; Kreutzburg T; Schermerhorn M; Bertges DJ; Larena-Avellaneda A; L'Hoest H; Kölbel T; Debus ES
Eur J Vasc Endovasc Surg; 2020 Apr; 59(4):587-596. PubMed ID: 31926836
[TBL] [Abstract][Full Text] [Related]
16. [Angioplasty with Sirolimus-coated Balloon: the New Standard in the Treatment of PAD?].
Teichgräber UK; Ingwersen M
Zentralbl Chir; 2023 Oct; 148(5):438-444. PubMed ID: 37846166
[TBL] [Abstract][Full Text] [Related]
17. Drug-Coated Balloons for Revascularization of Infrapopliteal Arteries: A Meta-Analysis of Randomized Trials.
Cassese S; Ndrepepa G; Liistro F; Fanelli F; Kufner S; Ott I; Laugwitz KL; Schunkert H; Kastrati A; Fusaro M
JACC Cardiovasc Interv; 2016 May; 9(10):1072-80. PubMed ID: 27131439
[TBL] [Abstract][Full Text] [Related]
18. Robustness of Longitudinal Safety and Efficacy After Paclitaxel-Based Endovascular Therapy for Treatment of Femoro-Popliteal Artery Occlusive Disease: An Updated Systematic Review and Meta-Analysis of Randomized Controlled Trials.
D'Oria M; Mastrorilli D; Secemsky E; Behrendt CA; Veraldi G; DeMartino R; Mani K; Budtz-Lilly J; Scali S; Saab F; Calvagna C; Mezzetto L; Ruaro B; Lepidi S
Ann Vasc Surg; 2024 Apr; 101():164-178. PubMed ID: 38154491
[TBL] [Abstract][Full Text] [Related]
19. Major adverse limb events in patients with femoro-popliteal and below-the-knee peripheral arterial disease treated with either sirolimus-coated balloon or standard uncoated balloon angioplasty: a structured protocol summary of the "SirPAD" randomized controlled trial.
Barco S; Sebastian T; Voci D; Engelberger RP; Grigorean A; Holy E; Leeger C; Münger M; Périard D; Probst E; Spescha R; Held U; Kucher N
Trials; 2022 Apr; 23(1):334. PubMed ID: 35449070
[TBL] [Abstract][Full Text] [Related]
20. Amputation-free Survival in Patients with Critical Limb Ischemia Treated with Paclitaxel-eluting Stents and Paclitaxel-coated Balloons.
Phair J; Carnevale M; Lipsitz EC; Shariff S; Scher L; Garg K
Ann Vasc Surg; 2020 Jan; 62():8-14. PubMed ID: 31207400
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
